Next Article in Journal
Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis
Next Article in Special Issue
HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways
Previous Article in Journal
Lignin and Cellulose Blends as Pharmaceutical Excipient for Tablet Manufacturing via Direct Compression
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Analysis of Panax ginseng Berries from Seven Cultivars Using UPLC-QTOF/MS and NMR-Based Metabolic Profiling

1
Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science, RDA, Eumseong 27709, Korea
2
Department of Oriental Medicine Biotechnology, Kyung Hee University, Yongin 17104, Korea
3
Department of Chemistry, Center for Proteome Biophysics, and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Korea
*
Author to whom correspondence should be addressed.
Biomolecules 2019, 9(9), 424; https://doi.org/10.3390/biom9090424
Submission received: 14 August 2019 / Revised: 27 August 2019 / Accepted: 27 August 2019 / Published: 28 August 2019
(This article belongs to the Special Issue Advances in Ginsenosides)

Abstract

:
The commercial use of Panax ginseng berries is increasing as P. ginseng berries are known to contain large amounts of ginsenosides, and many pharmacological activities have been reported for the various ginsenosides. For the proper use of P. ginseng berries, it is necessary to study efficient and accurate quality control and the profiling of the overall composition of each cultivar. Ginseng berry samples from seven cultivars (Eumseung, Chung-buk Province, Republic of Korea) were analyzed using ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC-QTOF/MS) for profiling of the ginsenosides, and high-resolution magic-angle-spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy for profiling of the primary metabolites. Comparing twenty-six ginsenoside profiles between the variant representatives and between the violet-stem variant, Kumpoong and Sunwon were classified. In the case of primary metabolites, the cultivars Kumpoong and Gopoong were classified. As a result of correlation analyses of the primary and secondary metabolites, in the Gopoong cultivar, the metabolism was found to lean toward energy metabolism rather than ginsenoside synthesis, and accumulation of osmolytes was low. The Gopoong cultivar had higher levels of most of the amino acids, such as arginine, phenylalanine, isoleucine, threonine, and valine, and it contained the highest level of choline and the lowest level of myo-inositol. Except for these, there were no significant differences of primary metabolites. In the Kumpoong cultivar, the protopanaxatriol (PPT)-type ginsenosides, ginsenoside Re and ginsenoside Rg2, were much lower than in the other cultivars, while the other PPT-type ginsenosides were inversely found in much higher amounts than in other cultivars. The Sunwon cultivar showed that variations of PPT-type ginsenosides were significantly different between samples. However, the median values of PPT-type ginsenosides of Sunwon showed similar levels to those of Kumpoong. The difference in primary metabolites used for metabolism for survival was found to be small in our results. Our data demonstrated the characteristics of each cultivar using profiling data of the primary and secondary metabolites, especially for Gopoong, Kumpoong, and Sunwon. These profiling data provided important information for further research and commercial use.

Graphical Abstract

1. Introduction

Panax ginseng C.A. Mey. is one of the most important herbal products today, and its root has been widely used as a constituent of traditional medicine in Korea and other countries [1].
P. ginseng root contains diverse bioactive compounds, and ginsenosides are the major components. Previously, a number of studies have reported that ginsenosides show various pharmacological properties such as antitumor, antidiabetes, antifatigue, antistress, antioxidative, and antiaging effects, as well as enhancement of the immune system [2,3,4,5].
Due to their utility, the interest in the therapeutic potential of ginsenosides has increased. Ginsenosides are distributed in several parts of the P. ginseng plant, including not only the root but also the leaves and berries. Different parts of the plant contain distinct constituent compositions, and therefore may have different pharmacological activities [6,7,8].
Most of the previous reports on this topic have focused on the ginseng root as a reservoir of ginsenosides. Recent studies have also demonstrated that ginseng berries have a high content of ginsenosides, and their own various pharmacological properties [9,10,11,12].
Dey et al. compared the antihyperglycemic effect of both ginseng root and ginseng berries. They found that the berry exhibits more potent antihyperglycemic activity than the root, and only the berry shows marked antiobesity effects in mice [13].
Moreover, ginseng berry extract and compounds show potent antioxidative and antitumor activities [12,14,15].
In order to provide new insights for future study into P. ginseng berries, Lee et al. reviewed the chemical constituents and biological activities of the ginseng berry [16].
For the phytochemical study and quality control of ginseng berries, it is critical to assess the ginsenoside content in the berries. Analytical methods for assessing ginsenosides have been established by high-performance liquid chromatography (HPLC) coupled with a UV detector [6,17], or an evaporative light-scattering detector (ELSD) [18].
However, this method is limited to the simultaneous analysis of multiple target compounds. Additionally, such methods still lack the required sensitivity and selectivity to profile various ginsenosides. Recently, liquid chromatography (LC) coupled with mass spectrometry (MS) has emerged as a good tool for the sensitive and selective analysis of various ginsenosides. In particular, a quadrupole-time-of-flight (QTOF)/MS with ultra-performance liquid chromatography (UPLC) system is useful for the rapid and high-resolution separation of ginsenosides in ginseng [8,19,20].
The secondary metabolites of many plants have been studied extensively because they are characterized by the influence of plant characteristics and the environment. Although the primary metabolites are essential for growth and development, there is relatively less research focused on them compared to secondary metabolites. However, these secondary metabolites are produced from the primary metabolites. The study of primary metabolites, as well as secondary metabolites, is important in phytochemical research. For screening the major primary metabolites of a powdered sample, high-resolution magic-angle-spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy is a good tool without requiring extraction of the sample. The dipolar, chemical shift anisotropy and magnetic susceptibility interactions vanish when a powdered sample is spun with a magic angle (54.7°). Therefore, a reduced line width, which is similar to the resolution of the solution, can be observed by HR-MAS NMR spectroscopy [21].
Thus, in this study, UPLC-QTOF/MS was used to perform a comprehensive profiling of ginsenosides from extract of the ginseng berry and HR-MAS NMR spectroscopy was used to identify and quantify the major primary metabolites from a powder of the ginseng berry. The ginsenoside content and the major primary metabolites of ginseng berries may differ depending on the cultivars. The comprehensive profiling of various ginsenosides and the primary metabolites of the ginseng varieties that are currently grown by the National Institute of Horticultural and Herbal Science (NIHHS), Chunpoong, Chungsun, Kumpoong, Yunpoong, Gopoong, Sunwon, and Sunun, have not yet been fully reported. The metabolite profiling and classification of seven cultivars with this comparative method is applicable to the evaluation and control of the quality of ginseng berries.

2. Materials and Methods

2.1. Ginseng Berry Samples

Six-year-old ginseng berries were cultivated in the field of the Department of Herbal Crop Research (DHCR) located in Eumseung, Chung-buk Province (127˚45ʹ013.14ʹʹE, 36˚56ʹ36.63ʹʹN), Republic of Korea. This cultivation protocol was followed by the “ginseng GAP standard cultivation guideline” developed by the Rural Development Administration (RDA), Republic of Korea. On July 25, 2017, ginseng berries, randomly selected from those available on this date, were collected from the 10–15 samples of six-year-old ginseng of the seven cultivars (Figure 1). The seeds were removed from the ginseng berries, and the fruits were crushed and stored at –80 °C and freeze-dried by freeze dryer under reduced pressure (–30 °C, 100 mTorr) for 24 h. A voucher specimen (NIHHS-201707) was deposited at the Herbarium of DHCR, NIHHS, RDA, Republic of Korea.

2.2. Standard Constituents and Reagents

HPLC-grade acetonitrile, methanol, and water were obtained from Merck (Darmstadt, Germany). Formic acid, deuterium oxide (D2O), and 3-(trimethylsilyl) propionic-2,2,3,3-d4 acid sodium salt (TSP-d4) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The ginsenosides were isolated and purified from P. ginseng roots by a series of chromatography procedures in our laboratory, and their structures were elucidated by comparison of spectroscopic data (MS, 1H-NMR, and 13C-NMR) with the literature data: ginsenoside Rb1, Ra2, Ra3, Rc, Ra1, Rb2, Rb3, Rd, F2, Rg3, Rh2, compound K, 20-O-glucoginsenoside Rf, ginsenoside Rg1, Rg2, Re, Rf, Rh1, notoginsenoside R2, ginsenoside F1, Rg6, Rk1, Ro, and Rk3, ginsenoside F4, Rh4, and Rg5 [8]. The purity of the isolated compounds was determined to be more than 98% by normalization of the peak areas detected by HPLC analysis.

2.3. Sample Preparation

Ginseng berries were lyophilized and ground (<0.5 mm) using a mixer (Hanil, Seoul, Korea) and thoroughly mixed, and subsamples were homogenized further using a Retsch MM400 mixer mill (Retsch GmbH, Haan, Germany) for later analyses.
For the UPLC-QTOF/MS analysis, fine powder was weighed (100 mg), suspended in 1 mL of 70% (v/v) methanol, and ultrasonically extracted for 1 h at 50 °C. After the centrifugation (13,500× g, 5 min at 4 °C), 900 µL of supernatant was transferred to a new Eppendorf tube. The solution was filtered through a syringe PTFE filter (0.2 µm) and diluted 20 times. Each sample was injected directly into the UPLC system.
For the HR-MAS NMR analysis, each powder sample was weighed to give 3 mg and transferred to the NMR nano tube (Agilent Technologies, Santa Clara, CA, USA). For the NMR analysis, 37 μL of D2O containing 2 mM TSP-d4 was added to each NMR nanotube before the NMR measurement.

2.4. UPLC-QTOF/MS Analysis

UPLC was carried out on a Waters ACQUITY H-Class UPLC (Waters Corp, Milford, MA, USA) Chromatographic separations were performed on a Thermo Hypersil Gold column (2.1 mm × 100 mm, 1.9 µm). The column oven was maintained at 40 °C and the mobile phases consisted of solvent A [Water + 0.1% formic acid (v/v)] and solvent B [Acetonitrile + 0.1% formic acid (v/v)]. The elution gradient was as follows: 0–0.5 min, B 15%; 0.5–1 min, B 15–20%; 1–6 min, B 20%; 6–13 min, B 20–30%; 13–23 min, B 30–35%; 23–24 min, B 35–38%; 24–27 min, B 38–60%; 27–31 min, B 60–90%; 31–32 min, B 90–15%; 32–34 min, B 15%. The injection volume was 2 μL and the flow rate was 500 μL/min for each run. Methanol was run after every sample as a blank. Next, MS analysis was conducted on a Waters Xevo G2-S QTOF MS (Waters Corp.) in the negative ion mode. The mass spectrometers performed the MSE acquisition mode with alternative high- and low-energy scans. The operational parameters were set as follows: source temperature, 120 °C; desolvation temperature, 550 °C; cone voltage, 40 V; capillary, 3.0 kV; cone gas flow, 30 L/h; and desolvation gas flow, 800 L/h. Accurate mass measurements were achieved with the use of an automatic calibration delivery system, which contained the internal reference [Leucine-enkephalin, m/z 556.276 (ESI+), m/z 554.262 (ESI-)]. Data were collected from m/z 100 to 2000 [8].

2.5. HR-MAS NMR Analysis

All spectra were acquired with a 600.167 MHz Agilent NMR spectrometer equipped with a 4 mm gHX NanoProbe (Agilent technologies, Santa Clara, CA, USA). The spinning rate was 2000 Hz. A total of 128 transients were collected using CPMG (Carr–Purcell–Meiboom–Gill) with a PRESAT pulse sequence for the suppression of water and high molecular mass compounds [22]. The spectra were obtained using 1.704 s of acquisition time, 1 s of relaxation delay, and 128 transients. The TSP-d4 peak at 0.00 ppm was used for the reference to calibrate the chemical shift [23]. All spectra were phased and the baselines corrected manually. Metabolite assignment and quantification for each sample were processed using Chenomx NMR Suite 7.1 Professional (Chenomx Inc., Canada) and the Chenomx 600 MHz library database. For the multivariate statistical analysis, each NMR spectrum was binned from 0.5 to 8.0 ppm, and the water peak was excluded. The binning size was 0.001 ppm and normalization was conducted with total area. The binned spectra were aligned using the icoshift algorithm of MATLAB R2013b (The MathWorks, Natick, MA, USA). After the alignment, multivariate statistical analyses were conducted using SIMCA-P+ 12.0 software (Umetrics, Umeå, Sweden). The principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and orthogonal partial least squares discriminant analysis (OPLS-DA) were processed.

3. Results

3.1. Construction of LC-MS Conditions to Profile Various Ginsenosides

For a comprehensive profiling of various ginsenosides from the P. ginseng berry, an analytical method based on UPLC-QTOF/MS was constructed. Extracts of natural products generally have complex metabolites, including known and unknown compounds. To identify the metabolites in a mixture, it is critical to measure the exact mass values of target metabolites. QTOF/MS, which provides a full mass scan at high resolution, is an effective way to analyze ginsenosides in a complex mixture. Among the various ginsenosides, there are several isomers that have the same mass values but different molecular structures. To determine the isomers, chromatographic separation is also required. A UPLC system with a small particle size column provides the rapid and effective separation of various compounds, including isomers. Thus, we used UPLC-QTOF/MS to profile various ginsenosides from the ginseng berry.
First, 37 standard samples of ginsenosides were used to optimize the LC-MS conditions. In the negative mode of electrospray ionization (ESI), the 37 ginsenosides were mainly detected as [M − H] and [M + COOH] ions. Under a flow rate of 500 µL/min using a Thermo Hypersil Gold column (2.1 mm × 100 mm, 1.9 µm particle size), various ginsenoside standards were separated well and eluted in 34 min. Although several compounds were eluted at almost the same times, the exact mass values could differentiate the ginsenosides. For a reliable and high-throughput analysis of various ginsenosides from many ginseng berry samples, it is required to construct an in-house library for the ginsenosides. The molecular formula and retention time (RT) of 37 ginsenosides were listed in the library. The m/z of ions from the ginsenoside profile data was automatically matched to the library compounds.
To construct the in-house library for the 37 ginsenosides, the molecular formula of each compound was added into the UNIFI software (v1.8, Waters Corp., Milford, MA, USA).
Next, we optimized the protocols to extract the ginsenosides from the ginseng berries. For effective extraction, it is critical to select a suitable solvent. Previously, several solvents such as water, ethanol (EtOH), and methanol (MeOH) have been widely used to extract ginsenosides from ginseng berries. First, we tried to compare the extraction efficiency of both EtOH and MeOH. A cultivar of ginseng berry, called Kumpoong, was used in this experiment. The EtOH or MeOH extracts of the ginseng berry were subjected to UPLC-QTOF/MS analysis. There was no significant difference between these two solvents, and we selected MeOH.

3.2. Profiling of Various Ginsenosides from Seven Different Cultivars of Ginseng Berries

The UPLC-QTOF/MS-based metabolomics approach was applied to identify the ginsenosides. Total ion chromatograms were obtained from seven different cultivars of ginseng berries using optimized conditions for UPLC-QTOF/MS (Figure 2).
After metabolite profiling of individual samples by UPLC-QTOF/MS, each set of data was processed using the UNIFI software. Progenesis QI v2.3 (Nonlinear Dynamics, Newcastle, UK) was used for data processing, including peak picking, alignment, and univariate analysis for filtering the peaks as follows: fold change >2, and p-value < 0.05. In total, 5655 peaks were filtered, and then the peaks were matched with the ginsenoside library. Therefore, 26 ginsenosides were identified. Heatmap analysis was conducted with these ginsenoside profiles of representative cultivars in each variant (Figure 3A). Kumpoong in the yellow-berry variant showed a different pattern to the other cultivars, and Chunpoong in the orange-berry variant and Yunpoong in the violet-stem variant, which are native cultivars, had similar patterns to each other. On the other hand, in the results of heatmap analysis with four cultivars of the violet-stem variant, Sunwon showed patterns different from the other cultivars (Figure 3B).

3.3. Profiling of Primary Metabolites from Different Cultivars of Ginseng Berries Using HR-MAS NMR

The primary metabolites from seven different cultivars of ginseng berry were analyzed using HR-MAS NMR spectroscopy (Figures S1 and S2). The representative 1H-NMR spectrum is shown in Figure 4.
Twenty-four primary metabolites were identified and quantified, and a one-way analysis of variance (ANOVA) was conducted using MetaboAnalyst 4.0 (https://www.metaboanalyst.ca). In the results of the one-way ANOVAs on all cultivars, alanine, arginine, benzoate, choline, glucose, glutamate, lysine, methionine, phenylalanine, sucrose, tyrosine, valine, and myo-inositol were found to be the significant metabolites (p-value <0.05). In the comparison of the representative cultivars in each variant, glutamate, methionine, choline, glucose, asparagine, phenylalanine, and lysine were significant, and in the comparison of the four cultivars in the violet-stem variant, myo-inositol, alanine, sucrose, arginine, methionine, choline, valine, tyrosine, phenylalanine, glutamate, tryptophan, sn-glycero-3-phosphocholine, lysine, and fructose were significant.
Multivariate statistical analyses of the NMR spectra were conducted for a spectral pattern comparison of cultivars. Multivariate statistical analyses were performed on the Pareto-scaled NMR spectra of all samples. PCA, PLS-DA, and OPLS-DA were performed, but the clustering pattern was not good in the PCA models. PLS-DA and OPLS-DA showed the same clustering pattern, and OPLS-DA showed a clearer classification. Therefore, we presented the OPLS-DA score plots (Figure 5). The OPLS-DA score plot of representative cultivars in each variant showed the clustering of Chunpoong with Chungsun. Kumpoong was clearly differentiated. In the comparison of cultivars in the violet-stem variant, the score plot showed similar patterns for Sunun and Yunpoong.
However, Gopoong showed a clear classification. These clustering patterns were different from the results of UPLC-QTOF/MS. From this, it was predicted that the perturbation patterns of primary and secondary metabolites differed according to the cultivars.

3.4. Pearson Correlation Analysis of Metabolites

The results of clustering showed differences in the primary and secondary metabolites of different cultivars. These results suggest that the degree of metabolic pathway activation among cultivars may be different. Therefore, a Pearson correlation analysis was performed using MetaboAnalyst 4.0 (Xia Lab, McGill University, Montréal, Quebec, Canada) to confirm the correlation between the primary metabolites and the secondary metabolites, and to interrelate this with the metabolic pathway (Figure 6). Samples were normalized by a pooled sample from the Yunpoong cultivar, which is one of the native species. Log transformation was used to obtain a normal distribution. Data were scaled with Pareto scaling.
The range of the correlation coefficient (r) is from −1 to +1. In the case of a value less than 0, it is considered a negative correlation, and a value over 0 is considered a positive correlation [24]. The r value can be divided by the degree of correlation: 0.40–0.69, moderate correlation; 0.70–0.89, strong correlation; 0.90–1.00, very strong correlation [25].

4. Discussion

The purpose of this study was to investigate the metabolite profiles of various ginseng berry cultivars and to investigate the differences among the cultivars by profiling the primary metabolites, which are required for survival, and the ginsenosides, which are functional metabolites. From the analysis results, it was confirmed that the primary metabolites and ginsenosides were different among cultivars, and correlation analysis was performed to confirm the relationship between them. The r value obtained from the correlation analysis indicates the degree of correlation, and the interval is divided into specific standards. However, these standards are controversial, and researchers use different standards in various ways. In our results, the data was cut off based on the r value of 0.4. Most of the amino acids which had r values > 0.4 with ginsenosides showed negative correlations. Conversely, glucose had positive correlations with the ginsenosides, with an r value > 0.4. These metabolites are all on the energy metabolic pathway, and the cultivars that had abundant glucose had also abundant ginsenosides (Re, Rb1, Rb2, and Rg3(S)). The synthesis of ginsenosides requires acetyl-CoA which is formatted through glycolysis from glucose, therefore abundant glucose can make more ginsenosides. On the other hand, when acetyl-CoA is utilized in the synthesis of ginsenosides, amino acids should supplement the acetyl-CoA and TCA intermediates for normal energy metabolism. Therefore, ginsenosides have negative correlations with amino acids (Figure 7) [26].
Sucrose synthesized from leaves is transported to nonphotosynthetic organs to supply energy and carbon skeletons [27]. Glucose is obtained from sucrose and used for synthesis of ginsenosides. Therefore, sucrose and ginsenosides showed negative correlations in our results. Choline is the precursor of glycinebetaine, which has the role of protecting plants from stress through the structural stabilization of complex proteins and membranes [28]. Myo-inositol is an osmolyte that plays an important role in phosphate storage, cell wall biosynthesis, stress-related molecular production, intercellular communication, and plant hormone transport [29]. From these results, choline and myo-inositol showed the opposite pattern of concentrations. Choline had a negative correlation with ginsenoside Rb1 and malonyl ginsenoside Rb1. On the other hand, myo-inositol had a positive correlation with them. These results were combined to link the more active metabolic pathway to the cultivars. The most specific cultivar was Gopoong. Most of the amino acids (arginine, phenylalanine, isoleucine, threonine, and valine) were present at higher levels in this cultivar, and most of the ginsenosides showed lower or similar levels than in the other cultivars. This seems to be due to normal energy metabolism rather than ginsenoside synthesis being prioritized in Gopoong. Gopoong contained the highest amount of choline among the cultivars, and the lowest amount of myo-inositol. It is thought to undergo less osmotic stress than the other cultivars. The other cultivars showed no significant differences in primary metabolites (Figure S3), and although the ginsenosides showed differences, they were not characteristic in the protopanaxadiol (PPD)-type (Figure S4). However, Kumpoong and Sunwon showed characteristic patterns in protopanaxatriol (PPT)-type ginsenosides (Figure 8). Notoginsenoside R1, R2, ginsenoside Rg1, Rh4, Rf, Rh1(S), and 20-O-glucoginsenoside Rf were present in higher levels in Kumpoong than in the other cultivars, while Re and Rg2 existed in much smaller amounts. In PPT-type ginsenosides, Sunwon showed a larger variation among samples than the other cultivars, however, the median values of these ginsenosides had levels similar to those of Kumpoong. Ginsenoside Rg4 and F4 were also weak, but showed patterns similar to Re and Rg2. Since there are few differences in the primary metabolites between cultivars, which are essential for general survival, there is little difference in the basic metabolism among the cultivars. However, the ginsenoside contents were different in each cultivar because of the different pathways and degree of response to the external environment in each cultivar.
These results can provide information on the cultivars that is useful for the production of pharmaceuticals, cosmetics, and so forth containing specific bioactivity. It is advantageous to use Chunpoong, Chungsun, Yunpoong, Gopoong, and Sunun for producing antidiabetic agents, based on the biological activity of ginsenoside Re [2,30,31,32]. On the other hand, the use of notoginsenoside R1, R2, ginsenoside Rg1, Rf, and Rh1-rich Kumpoong and Sunwon will be of benefit in the production of pharmaceuticals with neuroprotective effects [33,34,35,36,37,38,39,40] and cardioprotective effects [41,42,43,44,45].

5. Conclusions

This study was conducted to profile the overall metabolites of ginseng berries with pharmacological activities for commercial enhancement and quality control. There are various cultivars of ginseng berry, and representative cultivars of them were analyzed by UPLC-QTOF/MS and HR-MAS NMR spectroscopy for profiling of the primary and secondary metabolites. As a result, primary and secondary metabolites showed different patterns among cultivars. Therefore, the correlations between primary and secondary metabolites were analyzed. A characteristic metabolic pattern in Gopoong and the differential content of PPT-type ginsenosides in Kumpoong and Sunwon were confirmed. It was a new approach to the analysis of the correlation between primary and secondary metabolites in the ginseng berries. Through this study, it was possible to confirm the overall constituents by profiling the primary and secondary metabolites of the ginseng berry, and the characteristics of each variant were compared by confirming their differences.

Supplementary Materials

The following are available online at https://www.mdpi.com/2218-273X/9/9/424/s1, Figure S1: Representative 1H-NMR spectra of representative cultivars in each variant, Figure S2: Representative 1H-NMR spectra of cultivars in the violet-stem variant, Figure S3: Box plots of quantified primary metabolites, Figure S4: Box plots of quantified ginsenosides.

Author Contributions

Conceptualization, N.-I.B. and D.Y.L.; Data curation, D.Y.; Formal analysis, B.-R.C., S.M.O., H.-G.K. and S.K.; Investigation, D.Y.; Resources, Y.-C.K. and J.-U.K.; Writing – original draft, D.Y. and D.Y.L.; Writing – review & editing, D.Y.L.

Funding

This research was funded by the “Cooperative Research Program for Agriculture Science & Technology Development” (Project No. PJ01420402) of the Rural Development Administration, Republic of Korea.

Conflicts of Interest

The authors declare no conflicts of interest. The founding sponsors had no role in the design of the study; collection, analyses, or interpretation of the data; writing of the manuscript; or decision to publish the results.

Abbreviations

ANOVAanalysis of variance
ELSDevaporative light-scattering detector
ESIelectrospray ionization
HPLChigh-performance liquid chromatography
HR-MAShigh-resolution magic angle spinning
HR-MAShigh-resolution magic angle spinning
LODslimits of detection
MSmass spectrometry
NMRnuclear magnetic resonance
OPLS-DAorthogonal partial least squares discriminant analysis
PCAprincipal component analysis
PLS-DApartial least squares discriminant analysis
PPDprotopanaxadiol
PPTprotopanaxatriol
QTOFquadrupole time of flight
RTretention time

References

  1. Wang, Y.; Pan, J.Y.; Xiao, X.Y.; Lin, R.C.; Cheng, Y.Y. Simultaneous determination of ginsenosides in Panax ginseng with different growth ages using high-performance liquid chromatography–mass spectrometry. Phytochem. Anal. 2006, 17, 424–430. [Google Scholar] [CrossRef]
  2. Xie, J.-T.; Mehendale, S.R.; Li, X.; Quigg, R.; Wang, X.; Wang, C.-Z.; Wu, J.A.; Aung, H.H.; Rue, P.A.; Bell, G.I. Anti-diabetic effect of ginsenoside Re in ob/ob mice. BBA-Mol. Basis Dis. 2005, 1740, 319–325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Kenarova, B.; Neychev, H.; Hadjiivanova, C.; Petkov, V.D. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn. J. Pharmacol. 1990, 54, 447–454. [Google Scholar] [CrossRef] [PubMed]
  4. Yue, P.Y.K.; Mak, N.K.; Cheng, Y.K.; Leung, K.W.; Ng, T.B.; Fan, D.T.P.; Yeung, H.W.; Wong, R.N.S. Pharmacogenomics and the Yin/Yang actions of ginseng: Anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin. Med.-UK 2007, 2, 6. [Google Scholar] [CrossRef] [PubMed]
  5. Tang, W.; Zhang, Y.; Gao, J.; Ding, X.; Gao, S. The anti-fatigue effect of 20 (R)-ginsenoside Rg3 in mice by intranasally administration. Biol. Pharm. Bull. 2008, 31, 2024–2027. [Google Scholar] [CrossRef] [PubMed]
  6. Kang, O.-J.; Kim, J.-S. Comparison of Ginsenoside Contents in Different Parts of Korean Ginseng (Panax ginseng C.A. Meyer). Prev. Nutr. Food Sci. 2016, 21, 389–392. [Google Scholar] [CrossRef] [PubMed]
  7. Shi, W.; Wang, Y.T.; Li, J.; Zhang, H.Q.; Ding, L. Investigation of ginsenosides in different parts and ages of Panax ginseng. Food Chem. 2007, 102, 664–668. [Google Scholar] [CrossRef]
  8. Lee, J.W.; Choi, B.-R.; Kim, Y.-C.; Choi, D.J.; Lee, Y.-S.; Kim, G.-S.; Baek, N.-I.; Kim, S.-Y.; Lee, D.Y. Comprehensive Profiling and Quantification of Ginsenosides in the Root, Stem, Leaf, and Berry of Panax ginseng by UPLC-QTOF/MS. Molecules 2017, 22, 2147. [Google Scholar] [CrossRef]
  9. Attele, A.S.; Zhou, Y.P.; Xie, J.T.; Wu, J.A.; Zhang, L.; Dey, L.; Pugh, W.; Rue, P.A.; Polonsky, K.S.; Yuan, C.S. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002, 51, 1851–1858. [Google Scholar] [CrossRef] [PubMed]
  10. Jang, H.J.; Han, I.H.; Kim, Y.J.; Yamabe, N.; Lee, D.; Hwang, G.S.; Oh, M.; Choi, K.C.; Kim, S.N.; Ham, J.; et al. Anticarcinogenic Effects of Products of Heat-Processed Ginsenoside Re, a Major Constituent of Ginseng Berry, on Human Gastric Cancer Cells. J. Agric. Food Chem. 2014, 62, 2830–2836. [Google Scholar] [CrossRef]
  11. Mehendale, S.; Aung, H.; Wang, A.; Yin, J.-J.; Wang, C.-Z.; Xie, J.-T.; Yuan, C.-S. American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats. Cancer Chemother. Pharmacol. 2005, 56, 63–69. [Google Scholar] [CrossRef] [PubMed]
  12. Xie, J.-T.; Shao, Z.-H.; Vanden Hoek, T.L.; Chang, W.-T.; Li, J.; Mehendale, S.; Wang, C.-Z.; Hsu, C.-W.; Becker, L.B.; Yin, J.-J.; et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur. J. Pharmacol. 2006, 532, 201–207. [Google Scholar] [CrossRef] [PubMed]
  13. Dey, L.; Xie, J.T.; Wang, A.; Wu, J.; Maleckar, S.A.; Yuan, C.-S. Anti-hyperglycemic effects of ginseng: Comparison between root and berry. Phytomedicine 2003, 10, 600–605. [Google Scholar] [CrossRef] [PubMed]
  14. Xie, J.-T.; Du, G.-J.; McEntee, E.; Aung, H.H.; He, H.; Mehendale, S.R.; Wang, C.-Z.; Yuan, C.-S. Effects of Triterpenoid Glycosides from Fresh Ginseng Berry on SW480 Human Colorectal Cancer Cell Line. Cancer Res. Treat. 2011, 43, 49–55. [Google Scholar] [CrossRef] [PubMed]
  15. Shao, Z.-H.; Xie, J.-T.; Vanden Hoek, T.L.; Mehendale, S.; Aung, H.; Li, C.-Q.; Qin, Y.; Schumacker, P.T.; Becker, L.B.; Yuan, C.-S. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. BBA-Gen. Subj. 2004, 1670, 165–171. [Google Scholar] [CrossRef] [PubMed]
  16. Lee, S.Y.; Kim, Y.K.; Park, N.I.; Kim, C.S.; Lee, C.Y.; Park, S.U. Chemical constituents and biological activities of the berry of Panax ginseng. J. Med. Plants Res. 2010, 4, 349–353. [Google Scholar]
  17. Wang, C.-Z.; Wu, J.A.; MCENTEE, E.; Yuan, C.-S. Saponins Composition in American Ginseng Leaf and Berry Assayed by High-Performance Liquid Chromatography. J. Agric. Food Chem. 2006, 54, 2261–2266. [Google Scholar] [CrossRef]
  18. Kim, S.N.; Ha, Y.W.; Shin, H.; Son, S.H.; Wu, S.J.; Kim, Y.S. Simultaneous quantification of 14 ginsenosides in Panax ginseng CA Meyer (Korean red ginseng) by HPLC-ELSD and its application to quality control. J. Pharm. Biomed. 2007, 45, 164–170. [Google Scholar] [CrossRef]
  19. Mao, Q.; Bai, M.; Xu, J.-D.; Kong, M.; Zhu, L.-Y.; Zhu, H.; Wang, Q.; Li, S.-L. Discrimination of leaves of Panax ginseng and P. quinquefolius by ultra-high performance liquid chromatography quadrupole/time-of-flight mass spectrometry based metabolomics approach. J. Pharm. Biomed. Anal. 2014, 97, 129–140. [Google Scholar] [CrossRef]
  20. Xie, G.X.; Ni, Y.; Su, M.M.; Zhang, Y.Y.; Zhao, A.H.; Gao, X.F.; Liu, Z.; Xiao, P.G.; Jia, W. Application of ultra-performance LC-TOF MS metabolite profiling techniques to the analysis of medicinal Panax herbs. Metabolomics 2008, 4, 248–260. [Google Scholar] [CrossRef]
  21. Alam, T.M.; Jenkins, J.E. HR-MAS NMR spectroscopy in material science. In Advanced Aspects of Spectroscopy; IntechOpen: London, UK, 2012; pp. 279–306. [Google Scholar]
  22. Mun, J.-H.; Lee, H.; Yoon, D.; Kim, B.-S.; Kim, M.-B.; Kim, S. Discrimination of Basal Cell Carcinoma from Normal Skin Tissue Using High-Resolution Magic Angle Spinning 1H NMR Spectroscopy. PLoS ONE 2016, 11, e0150328. [Google Scholar] [CrossRef] [PubMed]
  23. Raja, G.; Kim, S.; Yoon, D.; Yoon, C.; Kim, S. 1H-NMR-based Metabolomics Studies of the Toxicity of Mesoporous Carbon Nanoparticles in Zebrafish (Danio rerio). Bull. Korean. Chem. Soc. 2017, 38, 271–277. [Google Scholar] [CrossRef]
  24. Sedgwick, P. Pearson’s correlation coefficient. BMJ 2012, 345, e4483. [Google Scholar] [CrossRef]
  25. Schober, P.; Boer, C.; Schwarte, L.A. Correlation coefficients: Appropriate use and interpretation. Anesth. Analg. 2018, 126, 1763–1768. [Google Scholar] [CrossRef] [PubMed]
  26. Vickers, C.E.; Williams, T.C.; Peng, B.; Cherry, J. Recent advances in synthetic biology for engineering isoprenoid production in yeast. Curr. Opin. Chem. Biol. 2017, 40, 47–56. [Google Scholar] [CrossRef]
  27. Ward, J.M.; Kühn, C.; Tegeder, M.; Frommer, W.B. Sucrose transport in higher plants. Int. Rev. Cytol. 1997, 178, 41–71. [Google Scholar]
  28. Falasca, A.; Melck, D.; Paris, D.; Saviano, G.; Motta, A.; Iorizzi, M. Seasonal changes in the metabolic fingerprint of Juniperus communis L. berry extracts by 1H NMR-based metabolomics. Metabolomics 2014, 10, 165–174. [Google Scholar] [CrossRef]
  29. Loewus, F.A.; Murthy, P.P. myo-Inositol metabolism in plants. Plant Sci. 2000, 150, 1–19. [Google Scholar] [CrossRef]
  30. Cho, W.C.; Chung, W.S.; Lee, S.K.; Leung, A.W.; Cheng, C.H.; Yue, K.K. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 2006, 550, 173–179. [Google Scholar] [CrossRef]
  31. Liu, Y.W.; Zhu, X.; Li, W.; Lu, Q.; Wang, J.Y.; Wei, Y.Q.; Yin, X.X. Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats. Pharmacol. Biochem. Behav. 2012, 101, 93–98. [Google Scholar] [CrossRef]
  32. Zhang, Z.; Li, X.; Lv, W.; Yang, Y.; Gao, H.; Yang, J.; Gao, H.; Yang, J.; Shen, Y.; Ning, G. Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-κB. Mol. Endocrinol. 2008, 22, 186–195. [Google Scholar] [CrossRef] [PubMed]
  33. Meng, X.; Wang, M.; Wang, X.; Sun, G.; Ye, J.; Xu, H.; Sun, X. Suppression of NADPH oxidase-and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia?reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways. Free Radic. Res. 2014, 48, 823–838. [Google Scholar] [CrossRef] [PubMed]
  34. Meng, X.; Sun, G.; Ye, J.; Xu, H.; Wang, H.; Sun, X. Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: A novel mechanism of Nrf2/ARE signaling activation. Free Radic. Res. 2014, 48, 445–460. [Google Scholar] [CrossRef] [PubMed]
  35. Zhai, Y.; Meng, X.; Luo, Y.; Wu, Y.; Ye, T.; Zhou, P.; Ding, S.; Wang, M.; Lu, S.; Zhu, L.; et al. Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Oncotarget 2018, 9, 9344. [Google Scholar] [CrossRef] [PubMed]
  36. Meng, X.B.; Sun, G.B.; Wang, M.; Sun, J.; Qin, M.; Sun, X.B. P90RSK and Nrf2 activation via MEK1/2-ERK1/2 pathways mediated by notoginsenoside R2 to prevent 6-hydroxydopamine-induced apoptotic death in SH-SY5Y cells. Evid. Based Complement. Altern. 2013, 2013, 1–15. [Google Scholar] [CrossRef] [PubMed]
  37. Chen, X.C.; Zhu, Y.G.; Zhu, L.A.; Huang, C.; Chen, Y.; Chen, L.M.; Fang, F.; Zhou, Y.C.; Zhao, C.H. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur. J. Pharmacol. 2003, 473, 1–7. [Google Scholar] [CrossRef]
  38. Chen, X.C.; Zhou, Y.C.; Chen, Y.; Zhu, Y.G.; Fang, F.; Chen, L.M. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress 1. Acta Pharmacol. Sin. 2005, 26, 56–62. [Google Scholar] [CrossRef] [PubMed]
  39. Jung, J.S.; Ahn, J.H.; Le, T.K.; Kim, D.H.; Kim, H.S. Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro invasion/migration of human astroglioma cells. Neurochem. Int. 2013, 63, 80–86. [Google Scholar] [CrossRef] [PubMed]
  40. Jung, J.S.; Kim, D.H.; Kim, H.S. Ginsenoside Rh1 suppresses inducible nitric oxide synthase gene expression in IFN-γ-stimulated microglia via modulation of JAK/STAT and ERK signaling pathways. Biochem. Biophys. Res. Commun. 2010, 397, 323–328. [Google Scholar] [CrossRef] [PubMed]
  41. Gai, Y.; Ma, Z.; Yu, X.; Qu, S.; Sui, D. Effect of ginsenoside Rh1 on myocardial injury and heart function in isoproterenol-induced cardiotoxicity in rats. Toxicol. Mech. Method 2012, 22, 584–591. [Google Scholar] [CrossRef] [PubMed]
  42. Yu, Y.; Sun, G.; Luo, Y.; Wang, M.; Chen, R.; Zhang, J.; Ai, Q.; Xing, N.; Sun, X. Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress-and endoplasmic reticulum stress-related signaling pathways. Sci. Rep.-UK 2016, 6, 21730. [Google Scholar] [CrossRef] [PubMed]
  43. Zhong, L.; Zhou, X.L.; Liu, Y.S.; Wang, Y.M.; Ma, F.; Guo, B.L.; Yan, Z.Q.; Zhang, Q.Y. Estrogen receptor α mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes. Mol. Med. Rep. 2015, 12, 119–126. [Google Scholar] [CrossRef] [PubMed]
  44. Ge, Z.R.; Xu, M.C.; Huang, Y.U.; Zhang, C.J.; Lin, J.E.; Ruan, C.W. Cardioprotective effect of notoginsenoside R1 in a rabbit lung remote ischemic postconditioning model via activation of the TGF? β1/TAK1 signaling pathway. Exp. Ther. Med. 2016, 11, 2341–2348. [Google Scholar] [CrossRef] [PubMed]
  45. Lee, H.; Gonzalez, F.J.; Yoon, M. Ginsenoside Rf, a component of ginseng, regulates lipoprotein metabolism through peroxisome proliferator-activated receptor α. Biochem. Biophys. Res. Commun. 2006, 339, 196–203. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Characteristics of the fruit of varieties of ginseng. (A) Chunpoong. The color of the berries is orange. (B) Chungsun. The color of the berries is red. (C) Kumpoong. The color of the berries is yellow. (D) Yunpoong. The color of the berries is red. (E) Gopoong. The color of the berries is red. (F) Sunun. The color of the berries is red. (G) Sunwon. The color of the berries is red.
Figure 1. Characteristics of the fruit of varieties of ginseng. (A) Chunpoong. The color of the berries is orange. (B) Chungsun. The color of the berries is red. (C) Kumpoong. The color of the berries is yellow. (D) Yunpoong. The color of the berries is red. (E) Gopoong. The color of the berries is red. (F) Sunun. The color of the berries is red. (G) Sunwon. The color of the berries is red.
Biomolecules 09 00424 g001
Figure 2. Representative ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC–QTOF/MS) total ion chromatograms (TIC) of ginseng berry extracts. (A) Comparison of representative cultivars in each variant (CP, Chunpoong; CS, Chungsun; KP, Kumpoong; YP, Yunpoong). (B) Comparison of cultivars in the violet-stem variant (YP, Yunpoong; GoP, Gopoong; SW, Sunwon; SU, Sunun). See retention time in Table 1.
Figure 2. Representative ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC–QTOF/MS) total ion chromatograms (TIC) of ginseng berry extracts. (A) Comparison of representative cultivars in each variant (CP, Chunpoong; CS, Chungsun; KP, Kumpoong; YP, Yunpoong). (B) Comparison of cultivars in the violet-stem variant (YP, Yunpoong; GoP, Gopoong; SW, Sunwon; SU, Sunun). See retention time in Table 1.
Biomolecules 09 00424 g002
Figure 3. Heatmap of ginsenoside profiles from different cultivars. (A) Comparison of representative cultivars in each variant (CP, Chunpoong; CS, Chungsun; KP, Kumpoong; YP, Yunpoong). (B) Comparison of cultivars in the violet-stem variant (YP, Yunpoong; GoP, Gopoong; SW, Sunwon; SU, Sunun).
Figure 3. Heatmap of ginsenoside profiles from different cultivars. (A) Comparison of representative cultivars in each variant (CP, Chunpoong; CS, Chungsun; KP, Kumpoong; YP, Yunpoong). (B) Comparison of cultivars in the violet-stem variant (YP, Yunpoong; GoP, Gopoong; SW, Sunwon; SU, Sunun).
Biomolecules 09 00424 g003
Figure 4. Representative 1H-nuclear magnetic resonance (NMR) spectrum with metabolite annotation. Ala, alanine; Arg, arginine; Asn, asparagine; Gln, glutamine; Glu, glutamate; Ile, isoleucine; Lys, lysine; Met, methionine; Phe, phenylalanine; Thr, threonine; Trp, tryptophan; Tyr, tyrosine; Val, valine.
Figure 4. Representative 1H-nuclear magnetic resonance (NMR) spectrum with metabolite annotation. Ala, alanine; Arg, arginine; Asn, asparagine; Gln, glutamine; Glu, glutamate; Ile, isoleucine; Lys, lysine; Met, methionine; Phe, phenylalanine; Thr, threonine; Trp, tryptophan; Tyr, tyrosine; Val, valine.
Biomolecules 09 00424 g004
Figure 5. Multivariate statistical analyses of NMR spectra from different cultivars. (A) Comparison of representative cultivars in each variant (, Chunpoong; , Chungsun; , Kumpoong; , Yunpoong). (B) Comparison of cultivars in violet-stem variant (, Gopoong; , Sunun; , Sunwon; , Yunpoong).
Figure 5. Multivariate statistical analyses of NMR spectra from different cultivars. (A) Comparison of representative cultivars in each variant (, Chunpoong; , Chungsun; , Kumpoong; , Yunpoong). (B) Comparison of cultivars in violet-stem variant (, Gopoong; , Sunun; , Sunwon; , Yunpoong).
Biomolecules 09 00424 g005
Figure 6. Correlation matrix of primary metabolites and ginsenosides. The scale bar shows the correlation coefficient from −1 to +1.
Figure 6. Correlation matrix of primary metabolites and ginsenosides. The scale bar shows the correlation coefficient from −1 to +1.
Biomolecules 09 00424 g006
Figure 7. Pathway of energy metabolism and ginsenoside synthesis. Selected correlation matrix plots of primary metabolites with r > 0.4 are shown for each ginsenoside.
Figure 7. Pathway of energy metabolism and ginsenoside synthesis. Selected correlation matrix plots of primary metabolites with r > 0.4 are shown for each ginsenoside.
Biomolecules 09 00424 g007
Figure 8. Box plots of protopanaxatriol (PPT)-type ginsenosides which showed characteristic patterns in the Kumpoong (KP) and Sunwon (SW) cultivars.
Figure 8. Box plots of protopanaxatriol (PPT)-type ginsenosides which showed characteristic patterns in the Kumpoong (KP) and Sunwon (SW) cultivars.
Biomolecules 09 00424 g008
Table 1. Relative percentages of ginsenosides in each cultivar (%).
Table 1. Relative percentages of ginsenosides in each cultivar (%).
No.Expected
RT (min)
Component NameFormulaObserved
m/z
Observed
RT (min)
AdductsAverage of Relative Percentage (%)
CPCSKPYPGoPSWSU
13.620-O-Glucoginsenoside RfC48H82O191007.5265 3.62+HCOO, -H0.07320.05630.29430.07640.08990.25390.0787
24.07Notoginsenoside R1C47H80O18977.5161 4.09+HCOO, -H0.04780.05700.74760.04090.05110.49650.0406
35.35Ginsenoside Rg1C42H72O14845.4773 5.45+HCOO, -H0.82970.26133.43800.55070.51162.48310.4419
45.66Ginsenoside ReC48H82O18991.5347 5.71+HCOO, -H6.77817.33954.57997.33726.78655.39046.7817
511.2vinaginsenoside R4C48H82O191007.5265 11.30+HCOO, -H0.24490.21950.24890.28050.24150.32900.2317
612.11Ginsenoside RfC42H72O14845.4770 12.17+HCOO, -H0.19920.11420.40250.19910.24140.33070.2202
712.81Notoginsenoside R2C41H70O13815.4644 12.89+HCOO, -H0.03680.05280.50080.01930.03840.28230.0203
813.43Ginsenoside F5C41H70O13815.4669 13.58+HCOO, -H0.48520.46370.45760.50500.48420.57960.4123
913.5620(S)-Ginsenoside Rh1C36H62O9683.4246 13.66+HCOO0.01280.00900.03540.01140.01190.02580.0107
1013.7Ginsenoside Rg2C42H72O13829.4824 13.79+HCOO, -H0.92500.90640.25980.90420.85040.45881.0673
1114.51Ginsenoside Ra3C59H100O271285.6185 14.27+HCOO, -H0.00330.00230.00320.00220.00260.00270.0031
1214.35Ginsenoside Ra2C58H98O261255.6049 14.52+HCOO, -H0.005400.00570.00510.00310.00270.0038
1314.53Ginsenoside Rb1C54H92O231153.5806 14.72+HCOO, -H0.50710.44110.47270.49990.32810.43260.4280
1415.12Malonyl ginsenoside Rb1C57H94O261193.5794 15.24-H3.08302.92412.60163.14622.57142.50603.1080
1515.69Ginsenoside RoC48H76O19955.4726 15.73-H0.04860.07050.05300.04370.06210.05060.0563
1616.3Ginsenoside Rb2C53H90O221123.5710 16.48+HCOO, -H0.99681.01241.13200.94670.93721.14410.9034
1718.34Ginsenoside RdC48H82O18991.5318 18.58+HCOO, -H1.68391.47161.77021.40301.41151.75131.3188
1819.11Malonyl ginsenoside RdC51H84O211031.5279 19.32-H5.01734.88324.38474.84145.13804.64404.9302
1923.46Ginsenoside Rg4C42H70O12811.4684 23.75+HCOO, -H0.04300.04890.02490.04590.03970.03100.0488
2023.5Compound OC47H80O17961.5136 23.77+HCOO, -H0.09300.04980.05270.04390.06100.03380.0317
2124.28Ginsenoside F4C42H70O12811.4695 24.52+HCOO, -H0.09640.11000.05660.10130.08640.06780.1077
2224.68Ginsenoside Rh4C36H60O8665.4140 24.90+HCOO0.00030.00010.00240.00030.00020.00160.0003
2325.19Ginsenoside F2C42H72O13829.4626 25.44+HCOO, -H0.06550.03460.02760.02380.03330.02010.0185
2426.01Ginsenoside Rg3-SC42H72O13829.4784 26.19+HCOO, -H0.02400.02520.02190.01980.02240.01990.0223
2527.35Compound KC36H62O8667.4320 27.54+HCOO0.00280.00600.00380.00390.00340.00380.0043
2627.55Ginsenoside Rg5C42H70O12811.4685 27.75-H0.01350.01530.01570.01350.01400.01340.0148

Share and Cite

MDPI and ACS Style

Yoon, D.; Choi, B.-R.; Kim, Y.-C.; Oh, S.M.; Kim, H.-G.; Kim, J.-U.; Baek, N.-I.; Kim, S.; Lee, D.Y. Comparative Analysis of Panax ginseng Berries from Seven Cultivars Using UPLC-QTOF/MS and NMR-Based Metabolic Profiling. Biomolecules 2019, 9, 424. https://doi.org/10.3390/biom9090424

AMA Style

Yoon D, Choi B-R, Kim Y-C, Oh SM, Kim H-G, Kim J-U, Baek N-I, Kim S, Lee DY. Comparative Analysis of Panax ginseng Berries from Seven Cultivars Using UPLC-QTOF/MS and NMR-Based Metabolic Profiling. Biomolecules. 2019; 9(9):424. https://doi.org/10.3390/biom9090424

Chicago/Turabian Style

Yoon, Dahye, Bo-Ram Choi, Young-Chang Kim, Seon Min Oh, Hyoung-Geun Kim, Jang-Uk Kim, Nam-In Baek, Suhkmann Kim, and Dae Young Lee. 2019. "Comparative Analysis of Panax ginseng Berries from Seven Cultivars Using UPLC-QTOF/MS and NMR-Based Metabolic Profiling" Biomolecules 9, no. 9: 424. https://doi.org/10.3390/biom9090424

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop